Workstream Type: Informing Dialogue

  • Medicare Part B Premium Dynamics Explained

  • Evaluating Industry’s Drug Pricing Claims

  • Mapping conflict of interests: scoping review

  • Production Plus Profit Pricing (P-quad) FAQ

  • Medicare Must Study Unproven, Expensive Alzheimer’s Drug

  • Trump’s Drug-Pricing Ideas Would Cost Taxpayers a Bundle

  • We can’t tackle the pandemic without figuring out which Covid-19 vaccines work the best

  • Instead of debating ‘first-shot’ vs ‘set-aside’ vaccine approaches, hospitals’ study should compare them

  • CMS’s Proposed Medicaid Best Price Loophole for Value-Based Purchasing of Drugs

  • The Science on Coronavirus is Topsy-Turvy. That’s Fine.